Gene Therapy

Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer

Physician’s Briefing

Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer

06 Aug 2026

1 min read

FDA Expands Use of First Sickle Cell Disease Gene Therapy for Children as Young as 2 Years

Physician’s Briefing

FDA Expands Use of First Sickle Cell Disease Gene Therapy for Children as Young as 2 Years

08 Jul 2026

2 min read

Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer

Physician’s Briefing

Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer

12 Jun 2026

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com